Skip to content
Accessibility help

Search NICE…

Skip to content

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE

Search results

Skip to results

Area of interest

Area of interestAntimicrobial prescribing (40)COVID-19 (35)

Type

TypeGuidance (4971)Indicators (320)News (352)NICE advice (498)Quality standards (257)Research recommendations (1786)

Status

StatusAwaiting development (376)Discontinued (467)In consultation (20)In development (391)Published (2574)Topic prioritisation (385)

Last updated

Last updatedLast 3 months (209)Last 6 months (382)Last year (707)Last 3 years (1439)

Guidance programme

Guidance programmeAntimicrobial prescribing guidelines (27)Antimicrobial resistance guidance (2)Cancer service guidelines (10)Clinical guidelines (391)COVID-19 rapid guidelines (27)Diagnostics guidance (89)Health technology evaluations (59)HealthTech guidance (778)Highly specialised technologies guidance (48)Interventional procedures guidance (1000)Medical technologies guidance (147)Medicines practice guidelines (5)NICE guidelines (577)Public health guidelines (89)Safe staffing guidelines (7)Social care guidelines (47)Technology appraisal guidance (2328)

Advice programme

Advice programmeCOVID-19 rapid summaries (8)Evidence summaries (172)Medtech innovation briefings (324)NICE reviews (2)

Showing 2281 to 2295 of 8932 results

Sort by

Mexiletine hydrochloride for treating myotonia in children and adolescents with myotonic disorders [TS ID 11978]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Veverimer for treating metabolic acidosis in chronic kidney disease [ID3832]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Evinacumab for treating homozygous familial hypercholesterolemia in children aged 6 months to 11 [TSID11806]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Pitolisant for treating narcolepsy in children and young people 6 to 17 years ID6353
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Mepolizumab for treating chronic obstructive pulmonary disease with eosinophil-associated exacerbations TSID12019
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
TVB-009 (denosumab biosimilar) for treating postmenopausal osteoporosis in people aged 60 to 90 [TSID11807]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Paclitaxel + XR17 (Paclical) with carboplatin for ovarian cancer [TSID5462]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Dupilumab for maintenance treatment of uncontrolled moderate to severe asthma in children 6 to 11 years [TSID10085]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Crizotinib for treating ALK-positive anaplastic large cell lymphoma or inflammatory myofibroblastic tumour in people 6 to 17 years [TSID10574]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Glatiramer acetate depot for multiple sclerosis [TSID10620]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Emtricitabine/tenofovir alafenamide for human immunodeficiency virus type-1 infection [TSID10723]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Darunavir plus cobicistat fixed dose combination for paediatric human immunodeficiency virus 1 infection [TSID10722]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Crizanlizumab for preventing recurrent vaso-occlusive crises in sickle cell disease in young people aged 12 to 17 [TSID10766]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
Dupilumab for children with severe atopic dermatitis [TSID10434]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation
CT-P43 (ustekinumab biosimilar) for treating moderate to severe plaque psoriasis [TSID11773]
Topic prioritisation
Result type
Technology appraisal guidance
Status
Topic prioritisation

Previous page
1
…
151
152
Current page 153
154
155
…
596
Page 153 of 596
Next page

Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS) Clinical Knowledge Summaries
British National Formulary (BNF) British National Formulary
BNF for Children (BNFC) British National Formulary for Children
Life sciences
Library and knowledge services

What NICE does
Implementing NICE guidance
Get involved
About us
Careers
News, blogs and podcasts
Newsletters and alerts
Contact us
Leave feedback
Reusing our content
NICE UK Open Content Licence
Syndicate our content
Events

Facebook
X
YouTube
LinkedIn

Accessibility
Freedom of information
Glossary
Terms and conditions
Privacy notice
Cookies

© NICE 2026. All rights reserved. Subject to Notice of rights.